Biologics

<!-- -->Shreehas Tambe was previously Deputy CEO of Biocon Biologics.New Delhi: Biocon Biologics today said it has elevated Shreehas Tambe as Managing Director and CEO (Chief Executive Officer) of the company with immediate…

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.' Photograph: PTI Photo   The market share that Biocon Biologics' insulin Glargine injection has gained in…

A special court dealing in a bribery case allegedly involving Biocon Biologics, a top official of the central drug regulator and a director of a Delhi-based company has said the allegations were "not only serious ... but of grave nature".…

A special CBI court on Tuesday rejected the bail pleas of all five people arrested in a case where Bengaluru-based Biocon Biologics is accused of bribing government officials dealing in a product approval. The CBI last month arrested…

<!-- -->Biocon Biologics has denied allegations of bribery against the company and officialsNew Delhi: Biocon Biologics, an arm of Biocon Ltd, on Tuesday denied allegations of bribery against the company and its officials regarding…

The Competition Commission of India (CCI) on Tuesday granted its approval to the acquisition of up to 24.98 per cent shareholding of IIFL Wealth Management Limited by BC Asia Investments X Ltd. It has also approved the proposed transaction…

Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices, and health clinics Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of…

PTI New Delhi, February 28In one of the largest deals in the pharma and healthcare space, Biocon on Monday said its subsidiary Biocon Biologics will…

<!-- -->Biocon Biologics will file for an IPO within the next two yearsNew Delhi: Biocon Biologics, a subsidiary of Biocon, will file for an initial public offer (IPO) within the next two years, Executive Chairperson Kiran…

HONG KONG: WuXi Biologics suspended trading in Hong Kong on Tuesday (Feb 8) following a record slump in its share price, after Washington added the Chinese pharmaceutical giant to a list that could restrict its US operations. The…